Nano-Codelivery of Temozolomide and siPD-L1 to Reprogram the Drug-Resistant and Immunosuppressive Microenvironment in Orthotopic Glioblastoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nano-Codelivery of Temozolomide and siPD-L1 to Reprogram the Drug-Resistant and Immunosuppressive Microenvironment in Orthotopic Glioblastoma
Authors
Keywords
-
Journal
ACS Nano
Volume 16, Issue 5, Pages 7409-7427
Publisher
American Chemical Society (ACS)
Online
2022-05-13
DOI
10.1021/acsnano.1c09794
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glioblastoma stem cell (GSC)-derived PD-L1-containing exosomes activates AMPK/ULK1 pathway mediated autophagy to increase temozolomide-resistance in glioblastoma
- (2021) Yong Zheng et al. Cell and Bioscience
- Chemoattractants driven and microglia based biomimetic nanoparticle treating TMZ-resistant glioblastoma multiforme
- (2021) Sai Qiao et al. JOURNAL OF CONTROLLED RELEASE
- Amplified antitumor efficacy by a targeted drug retention and chemosensitization strategy-based “combo” nanoagent together with PD-L1 blockade in reversing multidrug resistance
- (2021) Weixi Jiang et al. JOURNAL OF NANOBIOTECHNOLOGY
- Conjugation of glucosylated polymer chains to checkpoint blockade antibodies augments their efficacy and specificity for glioblastoma
- (2021) Tao Yang et al. Nature Biomedical Engineering
- The role of extracellular vesicles and PD-L1 in glioblastoma-mediated immunosuppressive monocyte induction
- (2020) Benjamin T Himes et al. NEURO-ONCOLOGY
- Deliver anti-PD-L1 into brain by p-hydroxybenzoic acid to enhance immunotherapeutic effect for glioblastoma
- (2020) Haiyan Guo et al. JOURNAL OF CONTROLLED RELEASE
- Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions
- (2020) Patrick Y Wen et al. NEURO-ONCOLOGY
- Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR delivery
- (2020) Achraf Noureddine et al. Acta Biomaterialia
- Lipid nanoparticles for nucleic acid delivery: Current perspectives
- (2020) Eleni Samaridou et al. ADVANCED DRUG DELIVERY REVIEWS
- Recent advances in siRNA delivery mediated by lipid-based nanoparticles
- (2020) Sei Yonezawa et al. ADVANCED DRUG DELIVERY REVIEWS
- Recent Advances of Polycationic siRNA Vectors for Cancer Therapy
- (2020) Raut Bholakant et al. BIOMACROMOLECULES
- Unraveling GLUT-mediated transcytosis pathway of glycosylated nanodisks
- (2020) Huan Wang et al. Asian Journal of Pharmaceutical Sciences
- Epigenetic modulator inhibition overcomes temozolomide chemoresistance and antagonizes tumor recurrence of glioblastoma
- (2020) Byoung-San Moon et al. JOURNAL OF CLINICAL INVESTIGATION
- RNA Interference Nanotherapeutics for Treatment of Glioblastoma Multiforme
- (2020) Prabhjeet Singh et al. MOLECULAR PHARMACEUTICS
- Small interfering RNA for cancer treatment: overcoming hurdles in delivery
- (2020) Nitin Bharat Charbe et al. Acta Pharmaceutica Sinica B
- Multifunctional ginsenoside Rg3-based liposomes for glioma targeting therapy
- (2020) Ying Zhu et al. JOURNAL OF CONTROLLED RELEASE
- Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
- (2019) Junfei Zhao et al. NATURE MEDICINE
- A Mn(III)-Sealed Metal-Organic Framework Nanosystem for Redox-Unlocked Tumor Theranostics
- (2019) Shuang-Shuang Wan et al. ACS Nano
- Cyanine-Gemcitabine Conjugates as Targeted Theranostic Agents for Glioblastoma Tumor Cells
- (2019) Zhengyang Jiang et al. JOURNAL OF MEDICINAL CHEMISTRY
- MRP1 modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cells
- (2019) Christine C. Gana et al. BIOCHEMICAL PHARMACOLOGY
- Relationship between protein biomarkers of chemotherapy response and microsatellite status, tumor mutational burden and PD‐L1 expression in cancer patients
- (2019) Mina Nikanjam et al. INTERNATIONAL JOURNAL OF CANCER
- Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme
- (2019) Lynn Jena et al. Drug Delivery and Translational Research
- Extracellular vesicle (ECV)-modified polyethylenimine (PEI) complexes for enhanced siRNA delivery in vitro and in vivo
- (2019) Petro Zhupanyn et al. JOURNAL OF CONTROLLED RELEASE
- Surface Functionalization of Polymeric Nanoparticles with Umbilical Cord-Derived Mesenchymal Stem Cell Membrane for Tumor-Targeted Therapy
- (2018) Na Yang et al. ACS Applied Materials & Interfaces
- Computational characterization of suppressive immune microenvironments in glioblastoma
- (2018) Suvi Luoto et al. CANCER RESEARCH
- Ten-year survival in glioblastoma. A systematic review
- (2018) Tomasz Tykocki et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Highly efficacious and specific anti-glioma chemotherapy by tandem nanomicelles co-functionalized with brain tumor-targeting and cell-penetrating peptides
- (2018) Yaqin Zhu et al. JOURNAL OF CONTROLLED RELEASE
- MgO nanoparticles cytotoxicity caused primarily by GSH depletion in human lung epithelial cells
- (2018) Mohd Javed Akhtar et al. JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
- The enhancement of siPLK1 penetration across BBB and its anti glioblastoma activity in vivo by magnet and transferrin co-modified nanoparticle
- (2018) Dao-zhou Liu et al. Nanomedicine-Nanotechnology Biology and Medicine
- Clinical implications of TERT promoter mutation on IDH mutation and MGMT promoter methylation in diffuse gliomas
- (2018) Hyun Sik Kim et al. PATHOLOGY RESEARCH AND PRACTICE
- Current Challenges and Opportunities in Treating Glioblastoma
- (2018) Andrea Shergalis et al. PHARMACOLOGICAL REVIEWS
- Selection of GalNAc-conjugated siRNAs with limited off-target-driven rat hepatotoxicity
- (2018) Maja M. Janas et al. Nature Communications
- β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species
- (2018) Yiming Bi et al. CANCER LETTERS
- Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma
- (2018) Rimas V. Lukas et al. JOURNAL OF NEURO-ONCOLOGY
- Genetic testing for high-grade osteosarcoma: a guide for future tailored treatments?
- (2018) Claudia Maria Hattinger et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- A novel RGDyC/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system
- (2018) Yanping Lu et al. International Journal of Nanomedicine
- Chemotherapy sensitization of glioblastoma by focused ultrasound-mediated delivery of therapeutic liposomes
- (2018) Alexandros Papachristodoulou et al. JOURNAL OF CONTROLLED RELEASE
- Angiopep-2-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) polymersomes for dual-targeting drug delivery to glioma in rats
- (2017) Fei Lu et al. International Journal of Nanomedicine
- Prognostic relevance of programmed cell death ligand 1 expression in glioblastoma
- (2017) Kyu Sang Lee et al. JOURNAL OF NEURO-ONCOLOGY
- Redox and pH dual sensitive bone targeting nanoparticles to treat breast cancer bone metastases and inhibit bone resorption
- (2017) Yi-pu Zhao et al. Nanoscale
- Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma
- (2017) Joseph P. Antonios et al. NEURO-ONCOLOGY
- Up-regulation of miR-497 confers resistance to temozolomide in human glioma cells by targeting mTOR/Bcl-2
- (2017) Danhua Zhu et al. Cancer Medicine
- Survival in glioblastoma: a review on the impact of treatment modalities
- (2016) P. D. Delgado-López et al. Clinical & Translational Oncology
- Endosomal acidic pH-induced conformational changes of a cytosol-penetrating antibody mediate endosomal escape
- (2016) Ji-Sun Kim et al. JOURNAL OF CONTROLLED RELEASE
- Clonal evolution of glioblastoma under therapy
- (2016) Jiguang Wang et al. NATURE GENETICS
- Clearance Pathways and Tumor Targeting of Imaging Nanoparticles
- (2015) Mengxiao Yu et al. ACS Nano
- Fusogenic Reactive Oxygen Species Triggered Charge-Reversal Vector for Effective Gene Delivery
- (2015) Xin Liu et al. ADVANCED MATERIALS
- Strategies to target drugs to gliomas and CNS metastases of solid tumors
- (2015) B. Milojkovic Kerklaan et al. JOURNAL OF NEUROLOGY
- PD-L1 expression and prognostic impact in glioblastoma
- (2015) Edjah K. Nduom et al. NEURO-ONCOLOGY
- MGMT testing allows for personalised therapy in the temozolomide era
- (2015) A. Dullea et al. TUMOR BIOLOGY
- Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance
- (2015) Malin Wickström et al. Nature Communications
- Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma
- (2014) Anna Sophie Berghoff et al. NEURO-ONCOLOGY
- Progress in developing cationic vectors for non-viral systemic gene therapy against cancer
- (2008) Marie Morille et al. BIOMATERIALS
- Mechanisms of BSO (L-buthionine-S,R-sulfoximine)-induced cytotoxic effects in neuroblastoma
- (2007) Barbara Marengo et al. FREE RADICAL BIOLOGY AND MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now